ABBV - Coherus to divest biosimilar against AbbVie's Humira for $40M
2024-06-27 14:07:44 ET
More on Coherus BioSciences
- Coherus BioSciences: CHS-114 Comes Into View At ASCO, Drug Launches Underway
- Coherus BioSciences, Inc. (CHRS) Q1 2024 Earnings Call Transcript
- Coherus BioSciences Non-GAAP EPS of -$0.32 misses by $0.11, revenue of $77.1M misses by $6.65M
- Coherus BioSciences Q1 2024 Earnings Preview
- Seeking Alpha’s Quant Rating on Coherus BioSciences